Hub ยท Peptide Science
Thymosin alpha-1: sequence, TB-500 and published research
Thymosin alpha-1 is a 28-amino-acid peptide first isolated from calf thymus. Its synthetic form is called thymalfasin (Dominari et al., 2020). Thymosin alpha-1 has a different amino acid sequence from full-length thymosin beta-4 and from TB-500, the short fragment of thymosin beta-4 identified by Esposito and colleagues in 2012.
01Identity and sequenceContents
When you see alpha-1 and beta-4 beside the name thymosin, the distinction is in the chains themselves. The letters in an amino acid sequence show which residues make up each chain and in what order. Counting those residues gives the chain length.
This peptide science guide follows the sequence records and a 2020 review of thymosin alpha-1. The guide to what peptides are explains how to read a peptide chain.
- Guidepeptide science guidePeptide science questions answered from published studies and regulator records: what peptides are, which are approved in Australia and by the FDA, and where research peptides sit.
- Guidewhat peptides areWhat peptides are: short chains of amino acids made by the body, some approved as medicines. Regulator and study evidence, safety records and Australian legal status. Research material is not a medicine.
Key facts
| First isolated from | Calf thymus (Goldstein et al., 1977) |
|---|---|
| Synthetic form | Thymalfasin (Dominari et al., 2020) |
| Chain length | 28 amino acids (Goldstein et al., 1977) |
| Research topics | T-cell maturation, dendritic-cell signalling and cytokines (Dominari et al., 2020) |
What is thymosin alpha-1?
Thymosin alpha-1 is a thymic peptide that Goldstein and colleagues first isolated from calf thymus and sequenced in 1977. Their paper reported 28 amino acids and an acetyl group attached at the start of the chain. Amino acid sequences are read from that end, called the N-terminus. Figure 2 of the original paper lists the first five residues as serine, aspartic acid, alanine, alanine and valine, or SDAAV in one-letter notation. The peptide bond guide explains how residues connect along the chain.
- Guidepeptide bond guideA peptide bond is the amide link that joins two amino acids. How it forms, where it sits, how to count bonds, which foods contain them, and what synthetic peptides and peptide vaccines are.
Is thymosin alpha-1 the same as TB-500 or thymosin beta-4?
Thymosin alpha-1 has its own sequence of 28 amino acids (Goldstein et al., 1977). Thymosin beta-4 has 43 amino acids (Low et al., 1981). Esposito and colleagues identified the seven-residue sequence LKKTETQ with an acetyl group at the start, written Ac-LKKTETQ, in a sample labelled TB-500. Those seven residues come from positions 17 to 23 of thymosin beta-4. The corresponding positions of thymosin alpha-1 read KEKKEVV in Figure 2 of the original sequencing paper. See TB-500 vs thymosin beta-4 for the evidence identifying the fragment.
GuideTB-500 vs thymosin beta-4TB-500 and thymosin beta-4 are not the same molecule in the papers that define them: a full-length protein against a short acetylated fragment, compared side by side.
What has published research studied about thymosin alpha-1?
Published research on thymosin alpha-1 has examined how T cells mature, how dendritic cells respond and how immune cells produce signalling proteins called cytokines. Dominari and colleagues covered these topics in their 2020 peer-reviewed review in the World Journal of Virology. The review discusses signalling through Toll-like receptors 2 and 9 in dendritic cells and other myeloid cells. It also describes research on interleukin-2, one of the cytokines discussed in connection with lymphocytes, a group of immune cells that includes T cells.
Evidence limits
What does the Australian register show for thymalfasin?
The Therapeutic Goods Administration's public Australian Register of Therapeutic Goods search for thymalfasin returned no matching results when checked on 19 November 2026. That result applies to the name searched. The TGA describes the register as a database of therapeutic goods that can be legally supplied in Australia. This article covers peptide identity, published research topics and that public register result. It shows no test result for any Form Laboratories product and gives no preparation or storage steps. Research use only.
Comparison
Chain length and amino acids at positions 17 to 23 of the full peptides. Esposito and colleagues identified that segment of thymosin beta-4 as the acetylated fragment in the TB-500 sample.
| Peptide | Chain length | Sequence at positions 17 to 23 or fragment sequence | Source |
|---|---|---|---|
| Thymosin alpha-1 | 28 amino acids | KEKKEVV | Goldstein et al., 1977, Figure 2 |
| Thymosin beta-4 | 43 amino acids | LKKTETQ | Low et al., 1981 and Esposito et al., 2012 |
| TB-500 fragment | 7 amino acids | Ac-LKKTETQ | Esposito et al., 2012 |
FAQ
What is thymosin alpha-1?
Thymosin alpha-1 is a peptide that Goldstein and colleagues sequenced from calf thymus in 1977. Each chain contains 28 amino acid residues.
Is thymosin alpha-1 the same as TB-500?
Thymosin alpha-1 and TB-500 are different peptides. The TB-500 sample analysed by Esposito and colleagues contained an acetylated piece of thymosin beta-4. Its amino acid sequence was LKKTETQ.
What is thymosin alpha-1 studied for?
The 2020 review by Dominari and colleagues discusses research on T-cell development, signalling through receptors in dendritic cells and the production of cytokines.
More in this hub
- GuidePeptide SciencePeptide science questions answered from published studies and regulator records: what peptides are, which are approved in Australia and by the FDA, and where research peptides sit.
- GuideIs SLU-PP-332 a peptide, and what harm record exists?SLU-PP-332 is a small molecule. Read what its chemistry record and mouse paper show, and why human side effects remain unknown.
- GuideWhat is SS-31, and did its trial measure weight loss?SS-31 is also called elamipretide. Read what its Barth syndrome trial measured, what the FDA approved, and why those findings cannot show weight loss.
- GuideWhich peptides are approved in Australia and by the FDA?Which peptide medicines the TGA and the FDA have approved, how approval differs from availability, and where research peptides sit, with records checked 14 October 2026.
- GuideWhat are peptides? Meaning, medicines, safety and legal status in AustraliaWhat peptides are: short chains of amino acids made by the body, some approved as medicines. Regulator and study evidence, safety records and Australian legal status. Research material is not a medicine.
- GuideWhat is a peptide bond? Peptide structure, chemistry and synthetic peptides explainedA peptide bond is the amide link that joins two amino acids. How it forms, where it sits, how to count bonds, which foods contain them, and what synthetic peptides and peptide vaccines are.
- GuideCitrullinated peptide antibodies: what anti-CCP is, why the test peptide is cyclic and how it is pronouncedAnti-CCP antibodies bind a lab-made cyclic peptide that contains citrulline. How citrullination works, why the test peptide is a ring, what the test measures, how the 2010 ACR/EULAR criteria use it, and how to say the name.
- GuidePeptide vs protein: what is the difference? Peptides compared with proteins, hormones, collagen and approved medicinesPeptide vs protein, hormone, steroid and collagen compared: size conventions, natural vs synthetic, research vs compounded, and what published trials and regulators record. Research material is not a medicine.
- GuideWhat do peptides do? What published studies foundWhat peptides do in the body, and what published studies found on weight, skin, growth hormone, joints and inflammation. Research material is not a medicine.
- GuidePeptide side effects: what studies and regulators have recordedAdverse events recorded for peptides in named trials, case reports, FDA and TGA documents, with study type, size and the limits of available human evidence.
- GuideDo peptides show up on drug tests? How peptides are tested and labelledWhether peptides show up on workplace and sport drug tests, how laboratories test peptide material for identity and purity, and what labelling a peptide means.
- GuideWhat have collagen peptide studies measured about muscle?What human collagen peptide studies measured about muscle protein building, body composition and strength, with the limits of each measurement explained.
- GuidePeptide solubility: what sequence, solvent, pH and aggregation doWhy some peptides dissolve and others do not: what two published studies report about sequence, solvent properties, pH and aggregation. Research reference only, with no preparation steps.
- GuideSolid-phase peptide synthesis: principle, limits and quality testingHow solid-phase peptide synthesis builds chains on an insoluble resin, why deletion and truncated by-products form, and what that means for analytical testing. Research reference only.
- GuidePeptide aggregation: physical association, sequence, interfaces and detectionHow peptide aggregation differs from chemical degradation, what a published review reports on sequence, surfaces, impurities and kinetics, and how aggregates are detected. Research reference only.
- GuidePeptide oxidation: chemical pathway, prone residues, triggers and detectionWhat peptide oxidation is as a chemical degradation pathway, which amino acid residues oxidise readily, what triggers oxidation, and how analytical methods detect it. Research reference only.
- GuideCell-penetrating peptides: classes, cellular entry pathways, prediction and delivery limitsWhat cell-penetrating peptides are, how cationic, amphipathic and hydrophobic classes differ, how direct translocation and endocytosis work, how sequences are predicted, and the known limits of cargo delivery. Research reference only.
- GuideWhat is a signal peptide, and how does it direct a protein?What a signal peptide sequence means, how cells recognise a protein's address, and why protein targeting differs from cosmetic signal-peptide language.
- GuideWhat is carnosine, and what do studies measure?Carnosine explained: its amino acid parts, acid buffering, chemical reactions, and what enzyme tests and human muscle measurements can establish.
- GuideWhat is CGRP, and how does its signalling work?CGRP explained: the body's nerve messenger, its CLR and RAMP1 receptor, cell signals, blood-vessel studies and the limits of each kind of evidence.
- GuideWhat is icotrokinra, and what do receptor studies measure?Learn what icotrokinra is, how the IL-23 receptor works, and why binding, cell signals and human biomarkers answer different research questions.
- GuideWhat is irisin, and how is it studied?Irisin explained: its relationship to FNDC5, protein and peptide terminology, cell signalling studies, human blood measurements and the limits of the evidence.
- GuideWhat is lunasin, and what have studies measured?Lunasin is a soybean peptide studied through chemical analysis, cell experiments and human measurements. Learn what each study measured and what remains unknown.
- GuideWhat is pramlintide, and how does amylin signalling work?Pramlintide explained through amylin biology: peptide structure, receptor partners, cell signals, human study measurements and the limits of research material.
- GuideWhat is peptide YY, and what do studies measure?Peptide YY explained: the gut's natural signal, PYY forms and receptors, and what blood tests, animal experiments and human studies can show.
- GuideWhat does TAT-DATNT refer to in peptide research?The meaning of TAT-DATNT, its link to dopamine transporter research, a published sequence mismatch, and the limits of laboratory evidence.
Citations
4 sourcesDominari A, Hathaway D III, Pandav K, et al. World Journal of Virology. 2020;9(5):67-78 (PMID 33362999).
doi:10.5501/wjv.v9.i5.67- Sourcedoi:10.5501/wjv.v9.i5.67
Goldstein AL, Low TL, McAdoo M, et al. Proceedings of the National Academy of Sciences. 1977;74(2):725-729 (PMID 265536).
doi:10.1073/pnas.74.2.725Low TL, Hu SK, Goldstein AL. Proceedings of the National Academy of Sciences. 1981;78(2):1162-1166 (PMID 6940133).
doi:10.1073/pnas.78.2.1162Esposito S, Deventer K, Goeman J, Van der Eycken J, Van Eenoo P. Drug Testing and Analysis. 2012;4(9):733-738 (PMID 22962027).
doi:10.1002/dta.1402- Sourcedoi:10.1002/dta.1402
Continue
Explore peptide scienceForm Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.
